Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure

References

• Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860.
   PubMed Web of Science ®Google Scholar
• Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, . Coronary heart disease in HIV-infected individuals. J Acquired Immune Defic Syndr: JAIDS. 2003;33:506–512.
   PubMed Web of Science ®Google Scholar
• Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D, Clinical Epidemiology Group from the French Hospital D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003;17:2479–2486.
   PubMed Web of Science ®Google Scholar
• Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, . Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.
   PubMed Web of Science ®Google Scholar
• Seaberg EC, Munoz A, Lu M, Detels R, Margolick JB, Riddler SA, . Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005;19:953–960.
   PubMed Web of Science ®Google Scholar
• Palacios R, Santos J, Garcia A, Castells E, Gonzalez M, Ruiz J, . Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients. HIV Med. 2006;7:10–15.
   PubMed Web of Science ®Google Scholar
• Chow DC, Souza SA, Chen R, Richmond-Crum SM, Grandinetti A, Shikuma C. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy. HIV Clin Trials. 2003;4:411–416.
   PubMed Web of Science ®Google Scholar
• Jerico C, Knobel H, Montero M, Sorli ML, Guelar A, Gimeno JL, . Hypertension in HIV-infected patients: Prevalence and related factors. Am J Hypertens. 2005;18:1396–1401.
   PubMed Web of Science ®Google Scholar
• Grandominico JM, Fichtenbaum CJ. Short-term effect of HAART on blood pressure in HIV-infected individuals. HIV Clin Trials. 2008;9:52–60.
   PubMed Web of Science ®Google Scholar
• Thiebaut R, El-Sadr WM, Friis-Moller N, Rickenbach M, Reiss P, Monforte ADA, . Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther. 2005;10:811–823.
   PubMed Web of Science ®Google Scholar
• Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: Influence of combination antiretroviral therapy. J Hypertens. 2008;26:2126–2133.
   PubMed Web of Science ®Google Scholar
• Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: Results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis. 2003;22:731–736.
   PubMed Web of Science ®Google Scholar
• Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P, Sacchi P, . Hypertension among HIV patients: Prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21:1377–1382.
   PubMed Web of Science ®Google Scholar
• Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P, . Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37:292–298.
   PubMed Web of Science ®Google Scholar
• Baliga RS, Chaves AA, Jing L, Ayers LW, Bauer JA. AIDS-related vasculopathy: Evidence for oxidative and inflammatory pathways in murine and human AIDS. Am J Physiol Heart Circ Physiol. 2005;289:H1373–H1380.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS. 2004;18:1037–1041.
   PubMed Web of Science ®Google Scholar
• Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, . Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol. 2000;11:2079–2087.
   PubMed Web of Science ®Google Scholar
• Baekken M, Os I, Sandvik L, Oektedalen O. Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population. Nephrol Dial Transplant. 2008;23:3130–3137.
   PubMed Web of Science ®Google Scholar
• Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, . Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine. 2008;5:e203.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Beilin L, Parati G, Waeber B, White W. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit. 1999;4:319–331.
   PubMedGoogle Scholar
• Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, . Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–536.
   PubMed Web of Science ®Google Scholar
• Baekken M, Os I, Stenehjem A, Sandvik L, Oektedalen O. Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals. HIV Med. 2009;10:44–52.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, . Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring: 10-Year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508–515.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM, . C-reactive protein and the risk of developing hypertension [see comment]. JAMA. 2003;290:2945–2951.
   PubMed Web of Science ®Google Scholar
• Panoulas VF, Douglas KMJ, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, . Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford). 2007;46:1477–1482.
   PubMed Web of Science ®Google Scholar
• Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, . Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hypertension. 1997;30:1135–1143.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, . 2007 ESH–ESC practice guidelines for the management of arterial hypertension: ESH–ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751–1762.
   PubMed Web of Science ®Google Scholar
• O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, . Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697–701.
   PubMed Web of Science ®Google Scholar
• Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259:225–228.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Friz HP, . Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54:226–232.
   PubMed Web of Science ®Google Scholar
• Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M, . Increase in carotid intima-media thickness in grade I hypertensive subjects: White-coat versus sustained hypertension. Hypertension. 2008;51:1300–1305.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white coat effect. Hypertension. 1997;29:1218–1224.
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–857.
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, . Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981–1987.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM, Sesso HD, . Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007;49:304–310.
   PubMed Web of Science ®Google Scholar
• Engstrom G, Janzon L, Berglund G, Lind P, Stavenow L, Hedblad B, . Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol. 2002;22:2054–2058.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, . Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303–1307.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Shanker B-A, Davis A, Lockshin MD, Sammaritano L, Simantov R, . Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus [see comment]. [Erratum appears in N Engl J Med. 2006;355:1746]. N Engl J Med. 2003;349:2399–2406.
   PubMed Web of Science ®Google Scholar
• Khalsa A, Karim R, Mack WJ, Minkoff H, Cohen M, Young M, . Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study. AIDS. 2007;21:2539–2541.
   PubMed Web of Science ®Google Scholar
• Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS. 2006;20:1019–1026.
   PubMed Web of Science ®Google Scholar
• Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, . Cardiovascular disease risk factors in HIV patients – Association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179–1193.
   PubMed Web of Science ®Google Scholar
• O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2:397.
   PubMed Web of Science ®Google Scholar
• Stenehjem AE, Os I. Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension. Blood Press. 2004;13:214–224.
   PubMed Web of Science ®Google Scholar